Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG timing in HIV-exposed Ugandan infants
NCT02606526Phase 3Completed
- Sponsor
- Makerere University
- Start
- Jul 2016
- Primary completion
- Jun 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of bcg vaccine in Tuberculosis (TB), septicemia, diarrhoea, lower respiratory tract infection (LRTI), sponsored by Makerere University. Started Jul 2016; status: completed.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)septicemiadiarrhoealower respiratory tract infection (LRTI)
Beyond the preview
Go deeper on NCT02606526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02606526.